ExodusPoint Capital Management’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-283,982
| Closed | -$7.06M | – | 1777 |
|
|
2025
Q1 | $7.06M | Buy |
283,982
+71,158
| +33% | +$1.77M | 0.07% | 280 |
|
|
2024
Q4 | $4.01M | Buy |
212,824
+148,842
| +233% | +$2.8M | 0.03% | 463 |
|
|
2024
Q3 | $963K | Buy |
+63,982
| New | +$963K | 0.01% | 922 |
|
|
2024
Q2 | – | Sell |
-26,643
| Closed | -$779K | – | 1725 |
|
|
2024
Q1 | $779K | Buy |
+26,643
| New | +$779K | 0.01% | 913 |
|
|
2023
Q4 | – | Sell |
-14,707
| Closed | -$451K | – | 1835 |
|
|
2023
Q3 | $451K | Sell |
14,707
-8,908
| -38% | -$273K | ﹤0.01% | 1236 |
|
|
2023
Q2 | $946K | Buy |
23,615
+98
| +0.4% | +$3.93K | 0.01% | 1034 |
|
|
2023
Q1 | $960K | Sell |
23,517
-32,097
| -58% | -$1.31M | 0.01% | 1053 |
|
|
2022
Q4 | $2.15M | Buy |
+55,614
| New | +$2.15M | 0.03% | 585 |
|
|
2022
Q3 | – | Sell |
-17,069
| Closed | -$995K | – | 2143 |
|
|
2022
Q2 | $995K | Buy |
+17,069
| New | +$995K | 0.01% | 1033 |
|
|
2020
Q4 | – | Sell |
-12,173
| Closed | -$732K | – | 2201 |
|
|
2020
Q3 | $732K | Buy |
+12,173
| New | +$732K | 0.01% | 766 |
|
|
2020
Q1 | – | Sell |
-24,567
| Closed | -$1.11M | – | 1446 |
|
|
2019
Q4 | $1.11M | Buy |
24,567
+1,094
| +5% | +$49.6K | 0.02% | 461 |
|
|
2019
Q3 | $894K | Sell |
23,473
-24,485
| -51% | -$933K | 0.03% | 396 |
|
|
2019
Q2 | $2.09M | Buy |
+47,958
| New | +$2.09M | 0.08% | 130 |
|
|
2019
Q1 | – | Sell |
-7,786
| Closed | -$335K | – | 729 |
|
|
2018
Q4 | $335K | Buy |
+7,786
| New | +$335K | 0.02% | 178 |
|